Join
Live feed
·
PRReleasevia Quantisnow
IRIDEX Corporation logo

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

ByQuantisnow·Wall Street's wire, on your screen.
IRIX· IRIDEX Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IRIX (IRIDEX Corporation) and more on Quantisnow.